Cargando…

ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture

(1) Background: Male stress incontinence in patients with previously treated urethral or bladder neck stricture is a therapeutic challenge. The efficacy and safety of the adjustable trans-obturator male system (ATOMS) in these patients is unknown. (2) Methods: All patients with primary ATOMS implant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullate, Ane, Arance, Ignacio, Virseda-Chamorro, Miguel, Ruiz, Sonia, Szczesniewski, Juliusz, Téllez, Carlos, Queissert, Fabian, Dorado, Juan F., Angulo, Javier C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410097/
https://www.ncbi.nlm.nih.gov/pubmed/36013121
http://dx.doi.org/10.3390/jcm11164882
_version_ 1784775011621404672
author Ullate, Ane
Arance, Ignacio
Virseda-Chamorro, Miguel
Ruiz, Sonia
Szczesniewski, Juliusz
Téllez, Carlos
Queissert, Fabian
Dorado, Juan F.
Angulo, Javier C.
author_facet Ullate, Ane
Arance, Ignacio
Virseda-Chamorro, Miguel
Ruiz, Sonia
Szczesniewski, Juliusz
Téllez, Carlos
Queissert, Fabian
Dorado, Juan F.
Angulo, Javier C.
author_sort Ullate, Ane
collection PubMed
description (1) Background: Male stress incontinence in patients with previously treated urethral or bladder neck stricture is a therapeutic challenge. The efficacy and safety of the adjustable trans-obturator male system (ATOMS) in these patients is unknown. (2) Methods: All patients with primary ATOMS implants in our institution between 2014 and 2021 were included. The outcomes of patients with previously treated urethral or bladder neck stricture (≥6 months before ATOMS implant) and stable 16Ch urethral caliber were compared to those without a history of stricture. The primary endpoint was the dry patient rate, defined as the pad test ≤ 20 mL/day, and complication rate, including device removal. The secondary variable was self-perceived satisfaction using the Patient Global Impression of Improvement (PGI-I) scale. Wilcoxon rank sum test, Fisher’s exact test and logistic regression were performed. (3) Results: One hundred and forty-nine consecutive patients were included, twenty-one (14%) previously treated for urethral or bladder neck stricture (seven urethroplasty, nine internal urethrotomy and five bladder neck incision). After ATOMS adjustment, 38% of the patients with treated stricture were continent compared to 83% of those without (p < 0.0001). After weighted matched observations using propensity score pairing, the proportion of continent patients without a previous stricture was 56% (p = 0.236). Complications occurred in 29% of the patients with stricture and in 20% of those without (p = 0.34). The severity of the complications was distributed evenly among the groups (p = 0.42). Regarding self-perceived satisfaction with the implant, 90% of the patients with stricture perceived the results satisfactorily (PGI-I 1–3) compared to 97% of the rest (p = 0.167). Stricture was associated with radiotherapy (p < 0.0001) and time from prostatectomy to implantation (p = 0.012). There was a moderate correlation between previous stricture and the severity of incontinence, both evaluated according to the 24-h pad test (Rho = 0.378; p < 0.0001) and the ICIQ-SF questionnaire (Rho = 0.351; p < 0.0001). Multivariate analysis for the factors predictive of failure after ATOMS adjustment revealed previous stricture (OR 4.66; 95% CI 1.2–18.87), baseline 24-h pad test (per 100 mL, OR 1.28; 95% CI 1.09–1.52) and final cushion volume (per mL, OR 1.34; 95% CI 1.19–1.55). This model predicted dryness with an AUC of 92%. After the PSMATCH procedure using a propensity score, the model remained unchanged, with the previous stricture (OR 8.05; 95% CI 1.08–110.83), baseline 24-h pad test (per 100 mL, OR 1.53; 95% CI 1.15–2.26) and final cushion volume (per mL, OR 1.45; 95% CI 1.17–2) being independent predictors and an AUC of 93%. (4) Conclusions: ATOMS can be used to treat male stress incontinence in patients with a history of stricture, although the effectiveness of the device is reduced. On the other hand, the security and perceived satisfaction were equivalent for both groups.
format Online
Article
Text
id pubmed-9410097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94100972022-08-26 ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture Ullate, Ane Arance, Ignacio Virseda-Chamorro, Miguel Ruiz, Sonia Szczesniewski, Juliusz Téllez, Carlos Queissert, Fabian Dorado, Juan F. Angulo, Javier C. J Clin Med Article (1) Background: Male stress incontinence in patients with previously treated urethral or bladder neck stricture is a therapeutic challenge. The efficacy and safety of the adjustable trans-obturator male system (ATOMS) in these patients is unknown. (2) Methods: All patients with primary ATOMS implants in our institution between 2014 and 2021 were included. The outcomes of patients with previously treated urethral or bladder neck stricture (≥6 months before ATOMS implant) and stable 16Ch urethral caliber were compared to those without a history of stricture. The primary endpoint was the dry patient rate, defined as the pad test ≤ 20 mL/day, and complication rate, including device removal. The secondary variable was self-perceived satisfaction using the Patient Global Impression of Improvement (PGI-I) scale. Wilcoxon rank sum test, Fisher’s exact test and logistic regression were performed. (3) Results: One hundred and forty-nine consecutive patients were included, twenty-one (14%) previously treated for urethral or bladder neck stricture (seven urethroplasty, nine internal urethrotomy and five bladder neck incision). After ATOMS adjustment, 38% of the patients with treated stricture were continent compared to 83% of those without (p < 0.0001). After weighted matched observations using propensity score pairing, the proportion of continent patients without a previous stricture was 56% (p = 0.236). Complications occurred in 29% of the patients with stricture and in 20% of those without (p = 0.34). The severity of the complications was distributed evenly among the groups (p = 0.42). Regarding self-perceived satisfaction with the implant, 90% of the patients with stricture perceived the results satisfactorily (PGI-I 1–3) compared to 97% of the rest (p = 0.167). Stricture was associated with radiotherapy (p < 0.0001) and time from prostatectomy to implantation (p = 0.012). There was a moderate correlation between previous stricture and the severity of incontinence, both evaluated according to the 24-h pad test (Rho = 0.378; p < 0.0001) and the ICIQ-SF questionnaire (Rho = 0.351; p < 0.0001). Multivariate analysis for the factors predictive of failure after ATOMS adjustment revealed previous stricture (OR 4.66; 95% CI 1.2–18.87), baseline 24-h pad test (per 100 mL, OR 1.28; 95% CI 1.09–1.52) and final cushion volume (per mL, OR 1.34; 95% CI 1.19–1.55). This model predicted dryness with an AUC of 92%. After the PSMATCH procedure using a propensity score, the model remained unchanged, with the previous stricture (OR 8.05; 95% CI 1.08–110.83), baseline 24-h pad test (per 100 mL, OR 1.53; 95% CI 1.15–2.26) and final cushion volume (per mL, OR 1.45; 95% CI 1.17–2) being independent predictors and an AUC of 93%. (4) Conclusions: ATOMS can be used to treat male stress incontinence in patients with a history of stricture, although the effectiveness of the device is reduced. On the other hand, the security and perceived satisfaction were equivalent for both groups. MDPI 2022-08-19 /pmc/articles/PMC9410097/ /pubmed/36013121 http://dx.doi.org/10.3390/jcm11164882 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ullate, Ane
Arance, Ignacio
Virseda-Chamorro, Miguel
Ruiz, Sonia
Szczesniewski, Juliusz
Téllez, Carlos
Queissert, Fabian
Dorado, Juan F.
Angulo, Javier C.
ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
title ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
title_full ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
title_fullStr ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
title_full_unstemmed ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
title_short ATOMS (Adjustable Trans-Obturator Male System) in Patients with Post-Prostatectomy Incontinence and Previously Treated Urethral Stricture or Bladder Neck Contracture
title_sort atoms (adjustable trans-obturator male system) in patients with post-prostatectomy incontinence and previously treated urethral stricture or bladder neck contracture
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410097/
https://www.ncbi.nlm.nih.gov/pubmed/36013121
http://dx.doi.org/10.3390/jcm11164882
work_keys_str_mv AT ullateane atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT aranceignacio atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT virsedachamorromiguel atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT ruizsonia atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT szczesniewskijuliusz atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT tellezcarlos atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT queissertfabian atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT doradojuanf atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture
AT angulojavierc atomsadjustabletransobturatormalesysteminpatientswithpostprostatectomyincontinenceandpreviouslytreatedurethralstrictureorbladderneckcontracture